Mink Ventures Corporation (TSXV:MINK) ("Mink" or the "Company") today announced it has entered into a drill contract for its ...

Ahead of COP31 in Antalya, Zero Waste Forum and Festival positioned Istanbul as a platform linking international environmental diplomacy, practical implementation, public awareness and public ownershi ...

New leadership begins as the global allergy community advances the Vision Zero ambition of a future free from allergy and ...

After years of slowed collection activity, the IRS Automated Collection System is generating notices, liens, and levies again - and many taxpayers will receive letters about balances they had assumed ...

Apply before October 30, 2026, for a chance to win $2,500. ATLANTA, GA / ACCESS Newswire / June 19, 2026 / Van Sant Law's new Community Impact & Academic Excellence Scholarship promises $2,500 to a ...

A.I.S. Resources Limited (TSXV: AIS, OTC-Pink: AISSF, FRA: 5YH) ("A.I.S." or the "Company") announces a non-brokered private placement of ...

Share option scheme for senior executives and allocation of options 2026 At Mowi ASA's (the "Company") annual general meeting ("AGM") on 3 June 2026 the Board of Directors was ...

Aben Gold Corp. (TSX-V: ABM: (OTCID: ABNAF) (Frankfurt: ML1: ("Aben" or "the Company") announces that it has closed a non-brokered private placement ...

The annual general meeting of shareholders of AS Trigon Property Development (registry code: 10106774; hereinafter the "Company") was held on 19 June 2026 in Tallinn, Pärnu mnt 18. The annual general ...

Press Release Atos powers kick-off of new football season as 2026-27 Premier League fixtures revealed London, UK - June 19, 2026 - Atos, a global leader in AI-powered digital transformation ...

Laje AS, a company within Qben Infras subsidiary ININ Power can today announce that the company's electrification division has secured two new contracts and one letter of intent regarding project assi ...

Sanofi's Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated non-i ...